SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company with a current market capitalization of ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care, announced the pricing of its public offering of 5,882,353 shares at $1.70 per share, expecting to raise $10 million ...

Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/106.BfLtBoPo.js ...

HeartBeam system was recently cleared by the U.S. Food and Drug Administration (FDA) for comprehensive arrhythmia assessment 510(k) application submitted to the FDA for the Company’s ...

SANTA CLARA, Calif., February 13, 2025--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock As the U.S. stock market navigates a mixed landscape of earnings ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SANTA CLARA, Calif., January 29, 2025--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized ...

HeartBeam (NASDAQ: BEAT) , a medical technology company focused on cardiac care, announced the pricing of its public offering of 5,882,353 shares at ...

HeartBeam, Inc, a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease ...